Cargando…

Adjusting for Disease Severity Across ICUs in Multicenter Studies

OBJECTIVES: To compare methods to adjust for confounding by disease severity during multicenter intervention studies in ICU, when different disease severity measures are collected across centers. DESIGN: In silico simulation study using national registry data. SETTING: Twenty mixed ICUs in The Nethe...

Descripción completa

Detalles Bibliográficos
Autores principales: Brakenhoff, Timo B., Plantinga, Nienke L., Wittekamp, Bastiaan H. J., Cremer, Olaf, de Lange, Dylan W., de Keizer, Nicolet F., Bakhshi-Raiez, Ferishta, Groenwold, Rolf H. H., Peelen, Linda M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6629171/
https://www.ncbi.nlm.nih.gov/pubmed/31135497
http://dx.doi.org/10.1097/CCM.0000000000003822
_version_ 1783435060522778624
author Brakenhoff, Timo B.
Plantinga, Nienke L.
Wittekamp, Bastiaan H. J.
Cremer, Olaf
de Lange, Dylan W.
de Keizer, Nicolet F.
Bakhshi-Raiez, Ferishta
Groenwold, Rolf H. H.
Peelen, Linda M.
author_facet Brakenhoff, Timo B.
Plantinga, Nienke L.
Wittekamp, Bastiaan H. J.
Cremer, Olaf
de Lange, Dylan W.
de Keizer, Nicolet F.
Bakhshi-Raiez, Ferishta
Groenwold, Rolf H. H.
Peelen, Linda M.
author_sort Brakenhoff, Timo B.
collection PubMed
description OBJECTIVES: To compare methods to adjust for confounding by disease severity during multicenter intervention studies in ICU, when different disease severity measures are collected across centers. DESIGN: In silico simulation study using national registry data. SETTING: Twenty mixed ICUs in The Netherlands. SUBJECTS: Fifty-five–thousand six-hundred fifty-five ICU admissions between January 1, 2011, and January 1, 2016. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: To mimic an intervention study with confounding, a fictitious treatment variable was simulated whose effect on the outcome was confounded by Acute Physiology and Chronic Health Evaluation IV predicted mortality (a common measure for disease severity). Diverse, realistic scenarios were investigated where the availability of disease severity measures (i.e., Acute Physiology and Chronic Health Evaluation IV, Acute Physiology and Chronic Health Evaluation II, and Simplified Acute Physiology Score II scores) varied across centers. For each scenario, eight different methods to adjust for confounding were used to obtain an estimate of the (fictitious) treatment effect. These were compared in terms of relative (%) and absolute (odds ratio) bias to a reference scenario where the treatment effect was estimated following correction for the Acute Physiology and Chronic Health Evaluation IV scores from all centers. Complete neglect of differences in disease severity measures across centers resulted in bias ranging from 10.2% to 173.6% across scenarios, and no commonly used methodology—such as two-stage modeling or score standardization—was able to effectively eliminate bias. In scenarios where some of the included centers had (only) Acute Physiology and Chronic Health Evaluation II or Simplified Acute Physiology Score II available (and not Acute Physiology and Chronic Health Evaluation IV), either restriction of the analysis to Acute Physiology and Chronic Health Evaluation IV centers alone or multiple imputation of Acute Physiology and Chronic Health Evaluation IV scores resulted in the least amount of relative bias (0.0% and 5.1% for Acute Physiology and Chronic Health Evaluation II, respectively, and 0.0% and 4.6% for Simplified Acute Physiology Score II, respectively). In scenarios where some centers used Acute Physiology and Chronic Health Evaluation II, regression calibration yielded low relative bias too (relative bias, 12.4%); this was not true if these same centers only had Simplified Acute Physiology Score II available (relative bias, 54.8%). CONCLUSIONS: When different disease severity measures are available across centers, the performance of various methods to control for confounding by disease severity may show important differences. When planning multicenter studies, researchers should make contingency plans to limit the use of or properly incorporate different disease measures across centers in the statistical analysis.
format Online
Article
Text
id pubmed-6629171
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-66291712019-07-22 Adjusting for Disease Severity Across ICUs in Multicenter Studies Brakenhoff, Timo B. Plantinga, Nienke L. Wittekamp, Bastiaan H. J. Cremer, Olaf de Lange, Dylan W. de Keizer, Nicolet F. Bakhshi-Raiez, Ferishta Groenwold, Rolf H. H. Peelen, Linda M. Crit Care Med Online Clinical Investigations OBJECTIVES: To compare methods to adjust for confounding by disease severity during multicenter intervention studies in ICU, when different disease severity measures are collected across centers. DESIGN: In silico simulation study using national registry data. SETTING: Twenty mixed ICUs in The Netherlands. SUBJECTS: Fifty-five–thousand six-hundred fifty-five ICU admissions between January 1, 2011, and January 1, 2016. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: To mimic an intervention study with confounding, a fictitious treatment variable was simulated whose effect on the outcome was confounded by Acute Physiology and Chronic Health Evaluation IV predicted mortality (a common measure for disease severity). Diverse, realistic scenarios were investigated where the availability of disease severity measures (i.e., Acute Physiology and Chronic Health Evaluation IV, Acute Physiology and Chronic Health Evaluation II, and Simplified Acute Physiology Score II scores) varied across centers. For each scenario, eight different methods to adjust for confounding were used to obtain an estimate of the (fictitious) treatment effect. These were compared in terms of relative (%) and absolute (odds ratio) bias to a reference scenario where the treatment effect was estimated following correction for the Acute Physiology and Chronic Health Evaluation IV scores from all centers. Complete neglect of differences in disease severity measures across centers resulted in bias ranging from 10.2% to 173.6% across scenarios, and no commonly used methodology—such as two-stage modeling or score standardization—was able to effectively eliminate bias. In scenarios where some of the included centers had (only) Acute Physiology and Chronic Health Evaluation II or Simplified Acute Physiology Score II available (and not Acute Physiology and Chronic Health Evaluation IV), either restriction of the analysis to Acute Physiology and Chronic Health Evaluation IV centers alone or multiple imputation of Acute Physiology and Chronic Health Evaluation IV scores resulted in the least amount of relative bias (0.0% and 5.1% for Acute Physiology and Chronic Health Evaluation II, respectively, and 0.0% and 4.6% for Simplified Acute Physiology Score II, respectively). In scenarios where some centers used Acute Physiology and Chronic Health Evaluation II, regression calibration yielded low relative bias too (relative bias, 12.4%); this was not true if these same centers only had Simplified Acute Physiology Score II available (relative bias, 54.8%). CONCLUSIONS: When different disease severity measures are available across centers, the performance of various methods to control for confounding by disease severity may show important differences. When planning multicenter studies, researchers should make contingency plans to limit the use of or properly incorporate different disease measures across centers in the statistical analysis. Lippincott Williams & Wilkins 2019-08 2019-07-12 /pmc/articles/PMC6629171/ /pubmed/31135497 http://dx.doi.org/10.1097/CCM.0000000000003822 Text en Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Online Clinical Investigations
Brakenhoff, Timo B.
Plantinga, Nienke L.
Wittekamp, Bastiaan H. J.
Cremer, Olaf
de Lange, Dylan W.
de Keizer, Nicolet F.
Bakhshi-Raiez, Ferishta
Groenwold, Rolf H. H.
Peelen, Linda M.
Adjusting for Disease Severity Across ICUs in Multicenter Studies
title Adjusting for Disease Severity Across ICUs in Multicenter Studies
title_full Adjusting for Disease Severity Across ICUs in Multicenter Studies
title_fullStr Adjusting for Disease Severity Across ICUs in Multicenter Studies
title_full_unstemmed Adjusting for Disease Severity Across ICUs in Multicenter Studies
title_short Adjusting for Disease Severity Across ICUs in Multicenter Studies
title_sort adjusting for disease severity across icus in multicenter studies
topic Online Clinical Investigations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6629171/
https://www.ncbi.nlm.nih.gov/pubmed/31135497
http://dx.doi.org/10.1097/CCM.0000000000003822
work_keys_str_mv AT brakenhofftimob adjustingfordiseaseseverityacrossicusinmulticenterstudies
AT plantinganienkel adjustingfordiseaseseverityacrossicusinmulticenterstudies
AT wittekampbastiaanhj adjustingfordiseaseseverityacrossicusinmulticenterstudies
AT cremerolaf adjustingfordiseaseseverityacrossicusinmulticenterstudies
AT delangedylanw adjustingfordiseaseseverityacrossicusinmulticenterstudies
AT dekeizernicoletf adjustingfordiseaseseverityacrossicusinmulticenterstudies
AT bakhshiraiezferishta adjustingfordiseaseseverityacrossicusinmulticenterstudies
AT groenwoldrolfhh adjustingfordiseaseseverityacrossicusinmulticenterstudies
AT peelenlindam adjustingfordiseaseseverityacrossicusinmulticenterstudies